Massachusetts Financial Services
DCPH

Massachusetts Financial Services’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History

Massachusetts Financial Services’s Portfolio DCPH Stock Details DCPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-13,219
Closed -$186K – 876
2023
Q2 		$186K Sell
13,219
-311
-2% -$4.45K ﹤0.01% 816
2023
Q1 		$209K Buy
+13,530
New +$226K ﹤0.01% 832

Other funds holding DCPH

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Massachusetts Financial Services's DCPH Position: Q3 2023 in Review

Massachusetts Financial Services sold out of Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) in Q3 2023, closing a stake of 13,219 shares — an estimated $186K sold.

Massachusetts Financial Services first reported a position in DCPH in Q1 2023 and held it in 2 quarters. The position peaked at $209K in Q1 2023. 157 funds tracked by Wall St. Rank hold DCPH as of Q3 2023.

  • Massachusetts Financial Services reported no remaining Deciphera Pharmaceuticals, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • Massachusetts Financial Services sold 13,219 Deciphera Pharmaceuticals, Inc. Common Stock shares in Q3 2023, an estimated $186K.
  • Massachusetts Financial Services first reported a position in Deciphera Pharmaceuticals, Inc. Common Stock in Q1 2023 and held it in 2 quarters.
  • Massachusetts Financial Services's Deciphera Pharmaceuticals, Inc. Common Stock position peaked at $209K in Q1 2023.
  • 157 funds tracked by Wall St. Rank held Deciphera Pharmaceuticals, Inc. Common Stock as of Q3 2023.

Based on Massachusetts Financial Services's 13F filing for Q3 2023, filed 8 Nov 2023.